首页 > 最新文献

Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)最新文献

英文 中文
New Strategies Using ‘Low-Dose’ Mycophenolate Mofetil to Reduce Acute Rejection in Patients following Kidney Transplantation 使用“低剂量”霉酚酸酯减少肾移植后患者急性排斥反应的新策略
P. Ulsh, Harold C. Yang, M. Holman, N. Ahsan
Journal of Transplant Coordination, Vol. 9, Number 2, June 1999 cyclosporine-based regimens, episodes of acute rejection exceed 50% in some centers. Several authors have demonstrated that the frequency and severity of these acute rejections significantly shorten the overall halflife of renal allografts.2,3 With this observation, many of the recent studies have used the number and severity of acute rejections as primary efficacy end point. New strategies using ‘low-dose’ mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation
移植协调杂志,第9卷,第2期,1999年6月,环孢素为基础的方案,急性排斥发作超过50%在一些中心。几位作者已经证明,这些急性排斥反应的频率和严重程度显著缩短了同种异体肾移植的总体半衰期。根据这一观察结果,最近的许多研究都使用急性排斥反应的数量和严重程度作为主要疗效终点。使用“低剂量”霉酚酸酯减少肾移植后患者急性排斥反应的新策略
{"title":"New Strategies Using ‘Low-Dose’ Mycophenolate Mofetil to Reduce Acute Rejection in Patients following Kidney Transplantation","authors":"P. Ulsh, Harold C. Yang, M. Holman, N. Ahsan","doi":"10.1177/090591999900900209","DOIUrl":"https://doi.org/10.1177/090591999900900209","url":null,"abstract":"Journal of Transplant Coordination, Vol. 9, Number 2, June 1999 cyclosporine-based regimens, episodes of acute rejection exceed 50% in some centers. Several authors have demonstrated that the frequency and severity of these acute rejections significantly shorten the overall halflife of renal allografts.2,3 With this observation, many of the recent studies have used the number and severity of acute rejections as primary efficacy end point. New strategies using ‘low-dose’ mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"9 1","pages":"114 - 118"},"PeriodicalIF":0.0,"publicationDate":"1999-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/090591999900900209","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65466014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Azathioprine Monotherapy in HLA-Identical Live Donor Kidney Transplant Recipients 硫唑嘌呤单药治疗hla相同活体肾移植受者
M. Bartucci, S. Fleming-Brooks, B. Koshla, T. Knauss, D. Hricik, J. Schulak
Journal of Transplant Coordination, Vol. 9, Number 1, March 1999 of hypertension,13-15 reduction in serum lipid levels,16-19 correction of posttransplant diabetes mellitus,19 and accelerated growth in children.20,21 Reported benefits of CsA withdrawal have included reduced cost and avoidance of long-term nephrotoxicity.10,11 Hypertension occurs in more than 50% of renal transplant recipients and has been attributed to multiple factors, including the presence of diseased native kidneys, acute and chronic allograft rejection, recurrence of original disease, and transplant renal artery stenosis. Although corticosteroids are known to elevate blood pressure in nontransplant patients, the role of these agents in the pathogenesis of posttransplant hypertension remains controversial. The influence of steroids has been further obscured by the routine use of CsA that also exacerbates posttransplant hypertension. However, studies have shown that cessation of steroids is accompanied by a significant decrease in mean arterial blood pressure and by a reduction in the number of required antihypertensive medications.6 , 7 , 1 2 1 5 Multivariate analysis in one study in which patients were maintained on AZA and CsA after steroid withdrawal showed the reduction in blood pressure was directly related to the prior severity of hypertension and inversely related to the dose of CsA.13 Hypercholesterolemia is common after renal transAzathioprine monotherapy in HLA-identical live donor kidney transplant recipients
高血压,13-15降低血脂水平,16-19纠正移植后糖尿病,19和加速儿童生长。20,21报道的停用CsA的好处包括降低成本和避免长期肾毒性。10,11超过50%的肾移植受者发生高血压,其原因是多种因素,包括原生肾脏病变、急性和慢性同种异体移植排斥反应、原发疾病复发和移植肾动脉狭窄。虽然已知皮质类固醇可升高非移植患者的血压,但这些药物在移植后高血压发病机制中的作用仍存在争议。常规使用CsA也会加剧移植后高血压,这进一步模糊了类固醇的影响。然而,研究表明,停止使用类固醇会显著降低平均动脉血压,减少所需抗高血压药物的数量。6, 7, 1 2 1 5在一项类固醇停药后继续服用AZA和CsA的研究中,多因素分析显示,血压的降低与先前高血压的严重程度直接相关,与CsA的剂量呈负相关13在hla相同的活体供体肾移植受者中,经硫唑嘌呤单药治疗后高胆固醇血症是常见的
{"title":"Azathioprine Monotherapy in HLA-Identical Live Donor Kidney Transplant Recipients","authors":"M. Bartucci, S. Fleming-Brooks, B. Koshla, T. Knauss, D. Hricik, J. Schulak","doi":"10.1177/090591999900900105","DOIUrl":"https://doi.org/10.1177/090591999900900105","url":null,"abstract":"Journal of Transplant Coordination, Vol. 9, Number 1, March 1999 of hypertension,13-15 reduction in serum lipid levels,16-19 correction of posttransplant diabetes mellitus,19 and accelerated growth in children.20,21 Reported benefits of CsA withdrawal have included reduced cost and avoidance of long-term nephrotoxicity.10,11 Hypertension occurs in more than 50% of renal transplant recipients and has been attributed to multiple factors, including the presence of diseased native kidneys, acute and chronic allograft rejection, recurrence of original disease, and transplant renal artery stenosis. Although corticosteroids are known to elevate blood pressure in nontransplant patients, the role of these agents in the pathogenesis of posttransplant hypertension remains controversial. The influence of steroids has been further obscured by the routine use of CsA that also exacerbates posttransplant hypertension. However, studies have shown that cessation of steroids is accompanied by a significant decrease in mean arterial blood pressure and by a reduction in the number of required antihypertensive medications.6 , 7 , 1 2 1 5 Multivariate analysis in one study in which patients were maintained on AZA and CsA after steroid withdrawal showed the reduction in blood pressure was directly related to the prior severity of hypertension and inversely related to the dose of CsA.13 Hypercholesterolemia is common after renal transAzathioprine monotherapy in HLA-identical live donor kidney transplant recipients","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"52 1","pages":"35 - 39"},"PeriodicalIF":0.0,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/090591999900900105","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65464924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Willingness to donate organs and tissues in Vietnam. 在越南捐献器官和组织的意愿。
T B Hai, T Eastlund, L A Chien, P T Duc, T H Giang, N T Hoa, P H Viet, D Q Trung

Context: Few studies on public attitudes toward organ and tissue donation have been carried out in Asia.

Objective: To determine demographic influences on attitudes toward organ and tissue donation in Vietnam.

Design: Face-to-face interviews.

Setting: Tan Binh District, Ho Chi Minh City, Vietnam.

Participants: Random sample of adults (N = 785).

Main outcome measures: Awareness of donation and transplantation, acceptance of organ and tissue donation.

Results: 75% of respondents stated they had heard of organ or tissue donation, but only 55% were aware of organ and tissue transplantation taking place in Vietnam. Forty-eight percent of Buddhists and 27.5% of Christians had either no knowledge or incorrect knowledge about their religion's official position toward donation and transplantation. Sixty-four percent stated they would give consent for the donation of their decreased relative's tissues and organs, 66% would themselves become posthumous donors, and 21% to 22% would donate multiple organs and tissues. A significant association was found between respondents' acceptance of organ and tissue donation and their educational level, sex, occupation, and awareness of transplantation. Most respondents stated that their willingness to donate depended on whether other family members agreed. Many noted the importance of preventing commerce in organ and tissue transplantation but were in favor of providing healthcare for the donor's family or monetary incentives as a reward for donating.

Conclusion: Nearly two thirds of urban Vietnamese surveyed were willing to donate organs or tissues after death. Their willingness was related to awareness of transplantation, sex, education level, and occupation.

背景:在亚洲,很少有关于公众对器官和组织捐赠态度的研究。目的:了解人口统计学对越南器官和组织捐赠态度的影响。设计:面对面的访谈。地点:越南胡志明市淡平区。参与者:成人随机抽样(N = 785)。主要观察指标:捐献和移植意识、接受器官和组织捐献。结果:75%的受访者表示他们听说过器官或组织捐赠,但只有55%的人知道在越南进行器官和组织移植。48%的佛教徒和27.5%的基督徒对他们的宗教对捐赠和移植的官方立场不了解或不正确。64%的人表示他们会同意捐赠逝去亲人的组织和器官,66%的人会在死后捐赠,21%到22%的人会捐赠多个器官和组织。受访者对器官和组织捐赠的接受程度与他们的教育水平、性别、职业和移植意识之间存在显著关联。大多数受访者表示,他们是否愿意捐赠取决于其他家庭成员是否同意。许多人注意到防止器官和组织移植交易的重要性,但赞成为捐赠者的家人提供医疗保健或提供金钱奖励,作为捐赠的奖励。结论:近三分之二的受访越南城市居民愿意在死后捐献器官或组织。其移植意愿与移植意识、性别、文化程度、职业有关。
{"title":"Willingness to donate organs and tissues in Vietnam.","authors":"T B Hai,&nbsp;T Eastlund,&nbsp;L A Chien,&nbsp;P T Duc,&nbsp;T H Giang,&nbsp;N T Hoa,&nbsp;P H Viet,&nbsp;D Q Trung","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Context: </strong>Few studies on public attitudes toward organ and tissue donation have been carried out in Asia.</p><p><strong>Objective: </strong>To determine demographic influences on attitudes toward organ and tissue donation in Vietnam.</p><p><strong>Design: </strong>Face-to-face interviews.</p><p><strong>Setting: </strong>Tan Binh District, Ho Chi Minh City, Vietnam.</p><p><strong>Participants: </strong>Random sample of adults (N = 785).</p><p><strong>Main outcome measures: </strong>Awareness of donation and transplantation, acceptance of organ and tissue donation.</p><p><strong>Results: </strong>75% of respondents stated they had heard of organ or tissue donation, but only 55% were aware of organ and tissue transplantation taking place in Vietnam. Forty-eight percent of Buddhists and 27.5% of Christians had either no knowledge or incorrect knowledge about their religion's official position toward donation and transplantation. Sixty-four percent stated they would give consent for the donation of their decreased relative's tissues and organs, 66% would themselves become posthumous donors, and 21% to 22% would donate multiple organs and tissues. A significant association was found between respondents' acceptance of organ and tissue donation and their educational level, sex, occupation, and awareness of transplantation. Most respondents stated that their willingness to donate depended on whether other family members agreed. Many noted the importance of preventing commerce in organ and tissue transplantation but were in favor of providing healthcare for the donor's family or monetary incentives as a reward for donating.</p><p><strong>Conclusion: </strong>Nearly two thirds of urban Vietnamese surveyed were willing to donate organs or tissues after death. Their willingness was related to awareness of transplantation, sex, education level, and occupation.</p>","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"9 1","pages":"57-63"},"PeriodicalIF":0.0,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21268927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Program Development and Routine Notification in a Large, Independent OPO: A 12-Year Review 大型独立OPO的项目开发和例行通知:12年回顾
T. Shafer, C. V. van Buren, Charles A. Andrews
Review of the Literature Shafer et al21 reported some of the first OPO benchmarking data available to the industry on what might result from successful organ recovery in defined geographic service areas. Evans1 reported that the potential for organ donation in the United States ranges from 27.6 to 42.8 donors per million population (pmp); according to Gortmaker et al,23 the potential ranges from 27.6 to 42.8 donors pmp. Nathan et al24 found that the potential donor pool in Pennsylvania in 1987 ranged from 38.3 to 55.2 donors pmp. Although OPOs have steadily applied numerous resources and countless hours in an attempt to maximize this potential, donation rates in the United States have stalled around 21 donors pmp, with OPOs in the upper quartile of production achieving greater than 24 donors pmp.25 The growth of organ recovery is stagnated for many reasons. Two of the reasons—lack of donor identification and lack of consent by families of the Program development and routine notification in a large, independent OPO: a 12-year review
文献综述Shafer等21报道了一些业界可获得的第一批OPO基准数据,这些数据是关于在确定的地理服务区域成功进行器官恢复可能产生的结果。Evans1报告说,在美国,器官捐赠的潜在数量在每百万人口27.6到42.8人之间;根据Gortmaker等人的研究,潜在供体数量在27.6到42.8之间。Nathan等人24发现1987年宾夕法尼亚州的潜在供体池在38.3到55.2个供体pmp之间。尽管opo已经稳定地投入了大量资源和无数时间,试图最大限度地发挥这一潜力,但美国的捐赠率一直停滞在每小时21个捐助者左右,产量最高的四分之一的opo的每小时捐赠率超过24个捐助者由于许多原因,器官恢复的增长停滞不前。其中两个原因是:缺乏捐助者身份证明,缺乏家庭对项目开发的同意,以及大型独立OPO的例行通知:12年审查
{"title":"Program Development and Routine Notification in a Large, Independent OPO: A 12-Year Review","authors":"T. Shafer, C. V. van Buren, Charles A. Andrews","doi":"10.1177/090591999900900106","DOIUrl":"https://doi.org/10.1177/090591999900900106","url":null,"abstract":"Review of the Literature Shafer et al21 reported some of the first OPO benchmarking data available to the industry on what might result from successful organ recovery in defined geographic service areas. Evans1 reported that the potential for organ donation in the United States ranges from 27.6 to 42.8 donors per million population (pmp); according to Gortmaker et al,23 the potential ranges from 27.6 to 42.8 donors pmp. Nathan et al24 found that the potential donor pool in Pennsylvania in 1987 ranged from 38.3 to 55.2 donors pmp. Although OPOs have steadily applied numerous resources and countless hours in an attempt to maximize this potential, donation rates in the United States have stalled around 21 donors pmp, with OPOs in the upper quartile of production achieving greater than 24 donors pmp.25 The growth of organ recovery is stagnated for many reasons. Two of the reasons—lack of donor identification and lack of consent by families of the Program development and routine notification in a large, independent OPO: a 12-year review","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"9 1","pages":"40 - 49"},"PeriodicalIF":0.0,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/090591999900900106","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65465264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Azathioprine monotherapy in HLA-identical live donor kidney transplant recipients. 硫唑嘌呤单药治疗hla相同活体肾移植受者。
M R Bartucci, S Flemming-Brooks, B Koshla, T C Knauss, D E Hricik, J A Schulak

The high success rate of HLA-identical sibling transplants and our previous experience with steroid-free immunosuppressive regimens and cyclosporine withdrawal prompted us to evaluate the safety and efficacy of monotherapy with azathioprine in 12 HLA-identical kidney transplant recipients with a serum creatinine concentration less than 176.8 mumol/L, a 1-way stimulatory index less than 2.0 in a post-transplant mixed lymphocyte culture, and a demonstrated tolerance of a minimum azathioprine dose of 1.0 mg/kg per day without leukopenia. Eleven of 12 patients were successfully converted to azathioprine monotherapy without a significant change in serum creatinine concentration for as long as 76 months. Benefits of steroid and cyclosporine withdrawal included a significant reduction in mean systolic and diastolic blood pressure, number of blood pressure medications, total serum cholesterol, and glycohemoglobin in diabetic subjects. Our results suggest that azathioprine monotherapy is safe and effective in a select group of HLA-identical sibling transplants, but these benefits must be carefully balanced against an associated risk of precipitating acute allograft rejection.

同种hla同胞移植的高成功率,以及我们之前无类固醇免疫抑制方案和环孢素停药的经验,促使我们对12例血清肌酐浓度低于176.8 mumol/L、移植后混合淋巴细胞培养的单向刺激指数低于2.0的同种hla肾移植受者进行了硫唑嘌呤单药治疗的安全性和有效性评估。并证明耐受最小硫唑嘌呤剂量为每天1.0 mg/kg,无白细胞减少。12例患者中有11例成功转换为硫唑嘌呤单药治疗,长达76个月,血清肌酐浓度无显著变化。停用类固醇和环孢素的益处包括显著降低糖尿病患者的平均收缩压和舒张压、降压药物的数量、血清总胆固醇和糖蛋白。我们的研究结果表明,硫唑嘌呤单药治疗在一组hla相同的同胞移植中是安全有效的,但这些益处必须仔细权衡引起急性同种异体移植排斥反应的相关风险。
{"title":"Azathioprine monotherapy in HLA-identical live donor kidney transplant recipients.","authors":"M R Bartucci,&nbsp;S Flemming-Brooks,&nbsp;B Koshla,&nbsp;T C Knauss,&nbsp;D E Hricik,&nbsp;J A Schulak","doi":"10.7182/prtr.1.9.1.v52h0082041k1751","DOIUrl":"https://doi.org/10.7182/prtr.1.9.1.v52h0082041k1751","url":null,"abstract":"<p><p>The high success rate of HLA-identical sibling transplants and our previous experience with steroid-free immunosuppressive regimens and cyclosporine withdrawal prompted us to evaluate the safety and efficacy of monotherapy with azathioprine in 12 HLA-identical kidney transplant recipients with a serum creatinine concentration less than 176.8 mumol/L, a 1-way stimulatory index less than 2.0 in a post-transplant mixed lymphocyte culture, and a demonstrated tolerance of a minimum azathioprine dose of 1.0 mg/kg per day without leukopenia. Eleven of 12 patients were successfully converted to azathioprine monotherapy without a significant change in serum creatinine concentration for as long as 76 months. Benefits of steroid and cyclosporine withdrawal included a significant reduction in mean systolic and diastolic blood pressure, number of blood pressure medications, total serum cholesterol, and glycohemoglobin in diabetic subjects. Our results suggest that azathioprine monotherapy is safe and effective in a select group of HLA-identical sibling transplants, but these benefits must be carefully balanced against an associated risk of precipitating acute allograft rejection.</p>","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"9 1","pages":"35-9"},"PeriodicalIF":0.0,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21268438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
The Use of Over-the-Counter Medications by Transplant Recipients: A Guideline 移植受者使用非处方药:指南
T. Ellingson, D. Wipke-Tevis, C. Messina, T. Livesay
Journal of Transplant Coordination, Vol. 9, Number 1, March 1999 The goals of this article are (1) to describe the usual immunosuppressants prescribed for transplant patients and the OTC medications used to manage symptoms of common ailments that may interact with immunosuppressants, and (2) to provide recommendations regarding which OTC medications have the least possible interactions or side effects.
移植协调杂志,第9卷,第1期,1999年3月,这篇文章的目的是(1)描述给移植患者开的常用免疫抑制剂,以及用于治疗可能与免疫抑制剂相互作用的常见疾病症状的非处方药,(2)提供有关哪些非处方药相互作用或副作用最小的建议。
{"title":"The Use of Over-the-Counter Medications by Transplant Recipients: A Guideline","authors":"T. Ellingson, D. Wipke-Tevis, C. Messina, T. Livesay","doi":"10.1177/090591999900900103","DOIUrl":"https://doi.org/10.1177/090591999900900103","url":null,"abstract":"Journal of Transplant Coordination, Vol. 9, Number 1, March 1999 The goals of this article are (1) to describe the usual immunosuppressants prescribed for transplant patients and the OTC medications used to manage symptoms of common ailments that may interact with immunosuppressants, and (2) to provide recommendations regarding which OTC medications have the least possible interactions or side effects.","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"9 1","pages":"17 - 24"},"PeriodicalIF":0.0,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/090591999900900103","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65465061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promoting Adherence to Transplant Medication Regimens: A Review of Behavioral Analysis 促进移植药物治疗方案的依从性:行为分析综述
S. Newton
Journal of Transplant Coordination, Vol. 9, Number 1, March 1999 administering the medications. However, studies have shown that at least one third of patients do not adhere to their drug regimens.3,4,5 Conrad4 suggests that compliance rates with medication regimens over long periods tend to approach 50%. It has also been shown that multiple medications and/or multiple doses per day of a medication—a common pattern for transplant recipients—tend to have higher rates of nonadherence.6 For transplant recipients, not adhering to the immunosuppressant regimen can result in rejection, graft loss, and even death.3 It has been documented that transplanted allografts are needlessly lost, due to recipient nonadherent behaviors.7 In one study,3 a third of liver transplant recipients were nonadherent with their immunosuppressant medication regimen. Perhaps the most surprising finding is that nonadherent behaviors generally occur when early posttransplant complications have been surpassed and long-term engraftment seems to have been achieved.7 According to some researchers, medication nonadherence causes more graft loss than does uncontrollable rejection in compliant recipients.3
移植协调杂志,第9卷第1期,1999年3月。然而,研究表明,至少有三分之一的患者没有坚持他们的药物治疗方案。3,4,5 Conrad4表明,长期服药的依从率接近50%。也有研究表明,多种药物和/或每天多次服用一种药物——这是移植接受者的常见模式——往往有更高的不依从率对于移植受者来说,不坚持免疫抑制疗法会导致排斥反应,移植物丢失,甚至死亡有文献记载,由于受体的不粘附行为,移植的同种异体移植物是不必要的损失在一项研究中,三分之一的肝移植受者对免疫抑制药物治疗方案没有依从性。也许最令人惊讶的发现是,非粘附行为通常发生在移植后早期并发症已经克服,长期植入似乎已经实现的情况下根据一些研究人员的说法,药物依从性不佳导致的移植物损失比依从性受体无法控制的排斥更严重
{"title":"Promoting Adherence to Transplant Medication Regimens: A Review of Behavioral Analysis","authors":"S. Newton","doi":"10.1177/090591999900900102","DOIUrl":"https://doi.org/10.1177/090591999900900102","url":null,"abstract":"Journal of Transplant Coordination, Vol. 9, Number 1, March 1999 administering the medications. However, studies have shown that at least one third of patients do not adhere to their drug regimens.3,4,5 Conrad4 suggests that compliance rates with medication regimens over long periods tend to approach 50%. It has also been shown that multiple medications and/or multiple doses per day of a medication—a common pattern for transplant recipients—tend to have higher rates of nonadherence.6 For transplant recipients, not adhering to the immunosuppressant regimen can result in rejection, graft loss, and even death.3 It has been documented that transplanted allografts are needlessly lost, due to recipient nonadherent behaviors.7 In one study,3 a third of liver transplant recipients were nonadherent with their immunosuppressant medication regimen. Perhaps the most surprising finding is that nonadherent behaviors generally occur when early posttransplant complications have been surpassed and long-term engraftment seems to have been achieved.7 According to some researchers, medication nonadherence causes more graft loss than does uncontrollable rejection in compliant recipients.3","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"167 1","pages":"13 - 16"},"PeriodicalIF":0.0,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/090591999900900102","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65464971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Discriminant Variables between Organ Donors and Nondonors: A Post Hoc Investigation 器官供者和非供者之间的判别变量:一项事后调查
J. Rosel, M. Frutos, M. Blanca, P. Ruiz
Journal of Transplant Coordination, Vol. 9, Number 1, March 1999 is difficult to obtain by any other means.8 The present study was conducted using data obtained from the close relatives of those who had been declared brain dead. Family members bore the main responsibility of deciding whether to donate the deceased’s organs. The goal of this study was to evaluate whether the families’ decision to donation was influenced by any of the following: their experiences during the loved one’s illness; the medical information they received; the explanation of brain death they were given; the hospital facilities; and social, demographic, and psychological factors. We hope that, based on this study, it will become clear which measures (eg, prodonation campaigns directed toward the general public or hospital staff) would be useful to promote organ donation.
《器官移植协调杂志》1999年3月第9卷第1期,很难通过其他途径获得目前的研究使用了从那些被宣布脑死亡的人的近亲那里获得的数据。是否捐献死者的器官,主要由家属决定。本研究的目的是评估家属的捐赠决定是否受到以下任何因素的影响:他们在亲人患病期间的经历;他们收到的医疗信息;他们给出了脑死亡的解释;医院设施;以及社会、人口和心理因素。我们希望,在这项研究的基础上,将明确哪些措施(例如,针对公众或医院工作人员的促进捐赠运动)将有助于促进器官捐赠。
{"title":"Discriminant Variables between Organ Donors and Nondonors: A Post Hoc Investigation","authors":"J. Rosel, M. Frutos, M. Blanca, P. Ruiz","doi":"10.1177/090591999900900107","DOIUrl":"https://doi.org/10.1177/090591999900900107","url":null,"abstract":"Journal of Transplant Coordination, Vol. 9, Number 1, March 1999 is difficult to obtain by any other means.8 The present study was conducted using data obtained from the close relatives of those who had been declared brain dead. Family members bore the main responsibility of deciding whether to donate the deceased’s organs. The goal of this study was to evaluate whether the families’ decision to donation was influenced by any of the following: their experiences during the loved one’s illness; the medical information they received; the explanation of brain death they were given; the hospital facilities; and social, demographic, and psychological factors. We hope that, based on this study, it will become clear which measures (eg, prodonation campaigns directed toward the general public or hospital staff) would be useful to promote organ donation.","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"5 1","pages":"50 - 53"},"PeriodicalIF":0.0,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/090591999900900107","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65465442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of over-the-counter medications by transplant recipients: a guideline. 移植受者使用非处方药:指南。
T Ellingson, D Wipke-Tevis, C Messina, T Livesay

Over-the-counter medications are becoming increasingly available to the general public. One of the issues facing clinicians working with transplant recipients is how to advise patients regarding management of symptoms associated with common ailments. Minimal literature is available to assist the transplant coordinators in this process. This article describes the usual immunosuppressants prescribed for transplant recipients and the over-the-counter medications used to manage these symptoms, and provides recommendations for over-the-counter medications with the least side effects.

普通大众越来越容易获得非处方药。与移植受者一起工作的临床医生面临的问题之一是如何建议患者处理与常见疾病相关的症状。在这个过程中,很少有文献可以帮助移植协调员。本文介绍了常用的免疫抑制剂和用于治疗这些症状的非处方药物,并提供了副作用最小的非处方药物的建议。
{"title":"The use of over-the-counter medications by transplant recipients: a guideline.","authors":"T Ellingson,&nbsp;D Wipke-Tevis,&nbsp;C Messina,&nbsp;T Livesay","doi":"10.7182/prtr.1.9.1.487821t0k2015512","DOIUrl":"https://doi.org/10.7182/prtr.1.9.1.487821t0k2015512","url":null,"abstract":"<p><p>Over-the-counter medications are becoming increasingly available to the general public. One of the issues facing clinicians working with transplant recipients is how to advise patients regarding management of symptoms associated with common ailments. Minimal literature is available to assist the transplant coordinators in this process. This article describes the usual immunosuppressants prescribed for transplant recipients and the over-the-counter medications used to manage these symptoms, and provides recommendations for over-the-counter medications with the least side effects.</p>","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"9 1","pages":"17-24"},"PeriodicalIF":0.0,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21268436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Dealing with the fear of mutilation in the donation discussion. 在捐赠讨论中处理对残割的恐惧。
M Verble, J Worth

Fear of mutilation is a significant barrier to organ and tissue donation. It constitutes an example of Mystical Thinking and may be seen as an exemplar of animal learning or, more specifically, as a representation of the "blood phobia." As such the fear is not amenable to conventional public education efforts. Cognitive and behavioral techniques used in treating other types of phobias should be studied as a way to remove this barrier to donation.

对残割的恐惧是器官和组织捐赠的一个重大障碍。它构成了神秘思维的一个例子,可以被视为动物学习的典范,或者更具体地说,作为“血恐惧症”的代表。因此,传统的公共教育努力无法消除这种恐惧。应该研究用于治疗其他类型恐惧症的认知和行为技术,以消除捐赠的这一障碍。
{"title":"Dealing with the fear of mutilation in the donation discussion.","authors":"M Verble,&nbsp;J Worth","doi":"10.7182/prtr.1.9.1.ng3r6718543619g4","DOIUrl":"https://doi.org/10.7182/prtr.1.9.1.ng3r6718543619g4","url":null,"abstract":"<p><p>Fear of mutilation is a significant barrier to organ and tissue donation. It constitutes an example of Mystical Thinking and may be seen as an exemplar of animal learning or, more specifically, as a representation of the \"blood phobia.\" As such the fear is not amenable to conventional public education efforts. Cognitive and behavioral techniques used in treating other types of phobias should be studied as a way to remove this barrier to donation.</p>","PeriodicalId":79507,"journal":{"name":"Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)","volume":"9 1","pages":"54-6"},"PeriodicalIF":0.0,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21268441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
期刊
Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1